A bill to make insulin more affordable could be up for a U.S. Senate vote as early as next month, [...] …
U.S. Sens. Susan Collins (R-Maine), left, and Jeanne Shaheen (D-N.H.) introduced bipartisan legislation to make insulin more affordable.
Month: June 2022
The U.S. Supreme Court opinion striking down huge cuts in 340B hospitals’ Medicare Part B drug reimbursement “is a clear and much welcome victory" for the hospitals, 340B Report Publisher and CEO Ted Slafsky says.
The U.S. Supreme Court opinion striking down big cuts in 340B hospitals’ Medicare Part B drug payments is a clear [...] …
The White House says this is the target month to release a long delayed proposed rule to replace the existing 340B ADR final rule. But it is unclear whether it will be delayed again.
The White House says this is the target month to release a proposed rule to replace the existing 340B ADR [...] …
A bill has been introduced in Congress that would get rid of a major barrier that prevents Ryan White clinics from providing PrEP to those at high risk of contracting the HIV/AIDS virus.
A bill has been introduced in Congress that would get rid of a major barrier that prevents Ryan White clinics [...] …
Gilead had added 45-day time limits for replenishment orders and claims submissions under its 340B contract pharmacy restrictions on Harvoni and its other branded hepatitis C medicines.
Gilead had added 45-day time limits for replenishment orders and claims submissions under its 340B contract pharmacy restrictions on Harvoni [...] …
Community health center (CHC) pharmacies, which have long operated with tight budgets, have recently been further weighed down by a [...] …
Providers say claims have been reversed without notice or explanation for 340B-purchased drugs that CVS Specialty dispensed to BCBS FEP participants.
Providers say claims have been reversed without notice or explanation for 340B-purchased drugs that CVS Specialty dispensed to BCBS FEP [...] …
The federal government wants an appeals court to rule that drug manufacturer AstraZeneca may not unilaterally dictate how many contract pharmacies a 340B covered entity may use to dispense 340B drugs.
The federal government wants an appeals court to rule that AstraZeneca may not dictate how many contract pharmacies a 340B [...] …
West Virginia has reinforced a 2019 law to bar PBMs or other payers from requiring hospitals such as CAMC and other health care providers to include claims modifiers when billing for 340B-purchased drugs.
A new West Virginia law clarifies that PBMs or other payers may not require a drug claim to include a modifier [...] …
The FTC and HHS asked for stakeholder feedback on generic drug shortages, which could have implications for the 340B program.
PhRMA and Community Oncology Alliance submitted comments to the FTC criticizing 340B contract pharmacy in response to the commission’s call [...] …
